Product Specifications
Active APIProduct NameLinezolid
CAS Registry Number165800-03-3
Molecule TypeSmall Molecule
Therapeutic CategoryAntibacterial
Development StatusDMF Filed
Regulatory Filings
USDMFE-DMF
Meet us at CPHI Milan 2026, Booth No. 10H33, Oct 6-8, Fiera Milano, Italy Schedule a Meeting
Linezolid API is an oxazolidinone-class antibiotic used to treat serious bacterial infections, including pneumonia by inhibiting bacterial protein synthesis.
Small Molecule
Pharmacological Profile & Biological Activity
Linezolid is the first available oxazolidinone to inhibit bacterial protein synthesis by interfering with translation. Linezolid binds to a site on the bacterial 23S ribosomal RNA of the 50S subunit, which prevents the formation of a functional 70S initiation complex.
Disclaimer: No information in this Catalog – including any reference to any product or service – constitutes an offer for sale or be constructed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, under Bolar Provision the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of patent scenario for their respective markets and will be responsible for all patent related liabilities.